Elanco Animal Health (NYSE:ELAN) Announces Share Buyback Plan

Elanco Animal Health (NYSE:ELAN – Get Free Report) announced that its Board of Directors has approved a stock repurchase plan on Thursday, November 19th, RTT News reports. The company plans to buy back $600 million in outstanding shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Weiss Ratings upgraded Elanco Animal Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, September 4th. Morgan Stanley decreased their price objective on Elanco Animal Health from $26.00 to $25.00 and set an “equal weight” rating for the company in a report on Thursday, October 29th. Jefferies Financial Group cut Elanco Animal Health from a “buy” rating to a “hold” rating and lowered their target price for the company from $31.00 to $24.00 in a research report on Tuesday, October 20th. KeyCorp reaffirmed an “overweight” rating on shares of Elanco Animal Health in a research note on Monday, November 9th. Finally, Barclays boosted their price target on Elanco Animal Health from $30.00 to $32.00 and gave the stock an “overweight” rating in a research report on Thursday. Nine equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $30.36.

Check Out Our Latest Analysis on Elanco Animal Health

Elanco Animal Health Stock Down 1.4%

Elanco Animal Health stock opened at $26.32 on Friday. The stock has a market cap of $13.15 billion, a price-to-earnings ratio of -87.72, a PEG ratio of 2.26 and a beta of 1.73. The company has a current ratio of 2.09, a quick ratio of 1.07 and a debt-to-equity ratio of 0.55. The company’s 50-day moving average price is $23.59 and its two-hundred day moving average price is $23.92. Elanco Animal Health has a 52 week low of $19.40 and a 52 week high of $27.98.

Elanco Animal Health (NYSE:ELAN – Get Free Report) last issued its quarterly earnings results on Friday, November 6th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.07. The company had revenue of $1.26 billion during the quarter, compared to analyst estimates of $1.21 billion. Elanco Animal Health had a negative net margin of 2.86% and a positive return on equity of 8.80%. The business’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.19 EPS. Elanco Animal Health has set its Q4 2026 guidance at 0.160-0.190 EPS and its FY 2026 guidance at 1.170-1.200 EPS. On average, analysts expect that Elanco Animal Health will post 1.18 EPS for the current fiscal year.

Insider Buying and Selling

In other Elanco Animal Health news, insider Timothy Bettington sold 4,350 shares of the company’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $23.00, for a total value of $100,050.00. Following the completion of the sale, the insider directly owned 138,911 shares in the company, valued at $3,194,953. This represents a 3.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.14% of the stock is currently owned by insiders.

Elanco Animal Health Company Profile

(Get Free Report)

Elanco Animal Health is a global animal health company that develops, manufactures and markets products for companion animals and livestock. Its offerings include medicines, vaccines and other products intended to prevent and treat disease and support animal health. For pets, Elanco provides treatments for conditions including parasitic infections, pain and chronic diseases. Its livestock products support the health of animals such as cattle, poultry, swine and fish, serving producers and veterinarians.

Read More

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.